April 9, 2026 · Form 4 insider transaction
Savitz Ryan bought 8,224 shares of Dianthus Therapeutics, Inc. at $17.88 per share, a transaction worth $147.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.